COLL vs SNPS · P/E 17, rev $181.9M vs P/E 63, rev $7.05B
Collegium Pharmaceutical Inc (COLL) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the COLL and SNPS stock pages for the full models.
Not investment advice.